Seeking Alpha

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription...

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription medicine for the treatment of chronic constipation, in Japan. The drug was approved by the Japanese Ministry of Health, Labor and Welfare in Japan in June. ABT will promote and distribute Amitiza in Japan under the terms of a 2009 license agreement with SCMP.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs